43138 Federal Register / Vol. 74, No. 164 / Wednesday, August 26, 2009 / Notices 

Journal of Cereal Science 47(2): 118–133, 

2008. 

37. Friedman, M., and C.E. Levin, ‘‘Review 

of methods for the reduction of dietary 

content and toxicity of acrylamide,’’ Journal 

of Agricultural and Food Chemistry 56(15): 

6113–40, 2008. 

38. Foot, R.J., N.U. Haase, K. Grob, and P. 

Gonde ́, ‘‘Acrylamide in fried and roasted 

potato products: a review on progress in 

mitigation,’’ Food Additives and 

Contaminants 24(Suppl 1): 37–46, 2007. 

39. Guenther, H., E. Anklam, T. Wenzl, and 

R.H. Stadler, ‘‘Acrylamide in coffee: review 

of progress in analysis, formation and level 

reduction,’’ Food Additives and 

Contaminants 24(Suppl 1): 60–70, 2007. 

40. Halford, N.G., N. Muttucumaru, T.Y. 

Curtis, and M.A. Parry, ‘‘Genetic and 

agronomic approaches to decreasing 

acrylamide precursors in crop plants,’’ Food 

Additives and Contaminants 24(Suppl 1): 

26–36, 2007. 

41. Konings, E.J., P. Ashby, C.G. Hamlet, 

and G.A. Thompson, ‘‘Acrylamide in cereal 

and cereal products: a review on progress in 

level reduction,’’ Food Additives and 

Contaminants 24(Suppl 1): 47–59, 2007. 

42. Morales, F., E. Capuano, and V. 

Fogliano, ‘‘Mitigation strategies to reduce 

acrylamide formation in fried potato 

products,’’ Annals of the New York Academy 

of Sciences 1126: 89–100, 2008. 

43. Muttucumaru, N., J.S. Elmore, T. 

Curtis, D.S. Mottram, M.A. Parry, and N.G. 

Halford, ‘‘Reducing acrylamide precursors in 

raw materials derived from wheat and 

potato,’’ Journal of Agricultural and Food 

Chemistry 56(15): 6167–72, 2008. 

44. Stadler, R.H., ‘‘Acrylamide formation in 

different foods and potential strategies for 

reduction,’’ Advances in Experimental 

Medicine and Biology 561: 157–169, 2005. 

45. Stadler, R.H., and G. Scholz, 

‘‘Acrylamide: an update on current 

knowledge in analysis, levels in food, 

mechanisms of formation, and potential 

strategies of control,’’ Nutrition Reviews 

62(12): 449–67, 2004. 

46. Taeymans, D., A. Andersson, P. Ashby, 

I. Blank, P. Gonde ́, P. van Eijck, V. Faivre, 

S.P. Lalljie, H. Lingnert, M. Lindblom, R. 

Matissek, D. Mu ̈ller, R.H. Stadler, A. Studer, 

D. Silvani, D. Tallmadge, G. Thompson, T. 

Whitmore, J. Wood, and D. Zyzak. 

‘‘Acrylamide: update on selected research 

activities conducted by the European food 

and drink industry,’’ Journal of AOAC 

International 88(1): 234–41, 2005. 

47. Taeymans, D., J. Wood, P. Ashby, I. 

Blank, A. Studer, R.H. Stadler, P. Gonde ́, P. 

Van Eijck, S. Lalljie, H. Lingnert, M. 

Lindblom, R. Matissek, D. Mu ̈ller, D. 

Tallmadge, J. O’Brien, S. Thompson, D. 

Silvani, and T. Whitmore, ‘‘A review of 

acrylamide: an industry perspective on 

research, analysis, formation, and control,’’ 

Critical Reviews in Food Science and 

Nutrition 44(5): 323–47, 2004. 

48. Zhang, Y., and Y. Zhang, ‘‘Formation 

and reduction of acrylamide in Maillard 

reaction: a review based on the current state 

of knowledge,’’ Critical Reviews in Food 

Science and Nutrition 47(5): 521–542, 2007. 

49. Confederation of Food and Drink 

Industries of the EU (CIAA), ‘‘The CIAA 

Acrylamide ‘Toolbox’, Revision 12,’’ 2009. 

Accessed online at http://www.ciaa.be/ 

documents/brochures/ 

ac_toolbox_20090216.pdf. 

50. CIAA, ‘‘A ‘Toolbox’ for the Reduction 

of Acrylamide in Biscuits, Crackers & 

Crispbreads,’’ 2007. Accessed online at 

http://www.ciaa.be/documents/others/ 

biscuits-EN-final.pdf. 

51. CIAA, ‘‘A ‘Toolbox’ for the Reduction 

of Acrylamide in Bread Products,’’ 2007. 

Accessed online at http://www.ciaa.be/ 

documents/others/bread-EN-final.pdf. 

52. CIAA, ‘‘A ‘Toolbox’ for the Reduction 

of Acrylamide in Breakfast Cereals,’’ 2007. 

Accessed online at http://www.ciaa.be/ 

documents/others/cereals-EN-final.pdf. 

53. CIAA, ‘‘A ‘Toolbox’ for the Reduction 

of Acrylamide in Fried Potato Products 

Potato Crisps,’’ 2007. Accessed online at 

http://www.ciaa.be/documents/others/crispsEN-final.pdf. 

54. CIAA, ‘‘A ‘Toolbox’ for the Reduction 

of Acrylamide in Fried Potato Products/ 

French Fries,’’ 2007. Accessed online at 

http://www.ciaa.be/documents/others/ 

french%20fries-EN-final.pdf. 

55. Association of the Chocolate, Biscuits, 

and Confectionery Industries of the EU 

(CAOBISCO), CAOBISCO Review of 

Acrylamide Mitigation in Biscuits, Crackers 

and Crispbread, 2006. Accessed online at 

http://www.caobisco.com/doc_uploads/ 

7254639e.pdf. 

56. The HEATOX Project, ‘‘Guidelines to 

Authorities and Consumer Organisations on 

Home Cooking and Consumption,’’ 2006. 

Accessed online at http://www.slv.se/upload/ 

heatox/documents/D59_guidelines_

to_authorities_and_consumer_organisations_

on_home_cooking_and_consumption.pdf. 

57. The HEATOX Project, ‘‘Manual on 

strategies to food industries, restaurants, etc., 

to minimize acrylamide formation,’’ 2006. 

Accessed online at http://www.slv.se/upload/ 

heatox/documents/D60_manual_

on_strategies_to_food_industries_

restaurants_etc_to_minimise_acrylamide_

formation.pdf. 

58. Joint FAO/WHO Food Standards 

Programme Codex Committee on 

Contaminants in Foods (CCCF), ‘‘Draft Code 

of Practice for the Reduction of Acrylamide 

in Foods (N06–2006),’’ In: Report of the 3rd 

Session of the CCCF, Rotterdam, The 

Netherlands, March 23–27 2009, ALINORM 

09/32/41, 2009, Appendix IV. Accessed 

online at http://www.codexalimentarius.net/ 

download/report/722/al32_41e.pdf. 

59. European Commission Joint Research 

Centre—Institute for Reference Materials and 

Measurements, ‘‘Monitoring database on 

acrylamide levels in food,’’ 2006. Accessed 

online at http://irmm.jrc.ec.europa.eu/html/ 

activities/acrylamide/database.htm. 

60. European Food Safety Authority 

(EFSA), ‘‘Call for occurrence data on 

acrylamide levels in food,’’ 2007. Accessed 

online at http://www.efsa.europa.eu/EFSA/ 

efsa_locale-1178620753812_

1178656289168.htm. 

61. The Commission of the European 

Communities, ‘‘Commission 

Recommendation of 3 May 2007 on the 

monitoring of acrylamide levels in food 

(2007/331/EC),’’ Official Journal of the 

European Union, 12/5/2007, L 123/33–40. 

Accessed online at http://eur-lex.europa.eu/ 

LexUriServ/site/en/oj/2007/l_123/ 

l_12320070512en00330040.pdf. 

62. Bundesamt fu ̈r Verbraucherschutz und 

Lebensmittelsicherheit (BVL), ‘‘Concept of 

minimising acrylamide contents in 

foodstuffs,’’ 2005. Accessed online at http:// 

www.bvl.bund.de/cln_007/nn_521138/EN/ 

01_Food/04_Acrylamid_en/acrylamid_

EN_node.html_nnn=true. 

63. Bonneck, S., ‘‘Acrylamide Risk 

Governance in Germany,’’ In O. Renn and 

K.D. Walker, Eds., Global Risk Governance, 

2008. Accessed online at http://www.irgc.org/ 

IMG/pdf/Chapter_11_Acrylamides_final.pdf. 

64. Health Canada, ‘‘Health Canada’s 

Acrylamide Monitoring Program,’’ 2009. 

Accessed online at http://www.hc-sc.gc.ca/ 

fn-an/securit/chem-chim/food-aliment/ 

acrylamide/monitoring-prog-surveillanceeng.php. 

65. Office of the Attorney General, State of 

California, News release: ‘‘Atty. Gen. Brown 

Settles Potato Chip Lawsuit With Heinz, 

Frito-Lay & Kettle Foods,’’ August 1, 2008. 

Accessed online at https://ag.ca.gov/ 

newsalerts/release.php?id=1595&. 

Dated: August 17, 2009. 

David Horowitz, 

Assistant Commissioner for Policy. 

[FR Doc. E9–20495 Filed 8–25–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–09–0789] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 or send 

comments to Maryam I. Daneshvar, CDC 

Acting Reports Clearance Officer, 1600 

Clifton Road, MS–D74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 74, No. 164 / Wednesday, August 26, 2009 / Notices 43139 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Program Effectiveness Evaluation of 

Workplace Intervention for Intimate 

Partner Violence (IPV)—[OMB# 0920– 

0789] [expiration date 12/31/09]— 

Extension—National Center for Injury 

Prevention and Control (NCIPC), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Intimate partner violence (IPV) affects 

a substantial number of Americans, and 

there has recently been increasing 

recognition of the impact it has on the 

workplace. In addition to direct impacts 

(batterers often stalk or even attack IPV 

victims at their place of work), IPV has 

indirect impacts on the workplace 

environment through lost productivity 

due to medical leave, absenteeism, and 

fear and distraction on the part of 

victims and coworkers. The Centers for 

Disease Control and Prevention (CDC) 

contracted with RTI International (RTI) 

to evaluate an ongoing workplace IPV 

prevention program being implemented 

at a national corporation. The purpose 

of the proposed evaluation is to 

document in detail the workplace IPV 

prevention activities delivered by the 

company, to determine the impact of 

these activities on short-term and longterm outcomes, and to determine the 

cost-effectiveness of the program. All 

managers at the corporate office of the 

corporation have been screened to 

assess training experiences. More indepth surveys were conducted with 

managers who had not completed the 

corporation’s IPV training. 

Approximately 200 managers have been 

surveyed at baseline, and 6 months 

later. Manager surveys focus on 

knowledge/awareness of IPV and 

company resources for IPV and number 

of referrals for IPV assistance. This 

extension is requested to cover the 12- 

month follow-up administration of this 

survey. Due to unexpected delays at the 

evaluation site and an inability to field 

the 6-month follow up survey with 

managers when originally scheduled, 

the project will need to be continued an 

additional 3 months. 

Employees (N = 400) of those 

managers who completed the baseline 

survey using an anonymous web-based 

survey at baseline have been surveyed. 

These employees will also be surveyed 

12 months later (during the 

reinstatement period) to assess their 

self-evaluated productivity, 

absenteeism, and perceptions of 

manager behavior. Responses of 

managers (and their employees) who 

received the IPV training in the study 

period (i.e., sometime between the 

baseline and 12 month surveys) with 

untrained managers will be compared. 

The study will provide CDC and 

employers information about the 

potential effectiveness and costeffectiveness of workplace IPV 

intervention strategies. 

There are no costs to respondents 

except their time to participate in the 

interview. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of responses per 

respondent 

Average 

burden per 

response (in 

hours) 

Total burden 

(in hours) 

Employee ......................................................................................................... 400 1 30/60 200 

Manager ........................................................................................................... 200 2 30/60 200 

Total .......................................................................................................... ........................ ........................ ........................ 400 

Dated: August 19, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–20578 Filed 8–25–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Grant Application Data 

Summary (GADS) Form. 

OMB No.: 0970–0328. 

Description: The Grant Application 

Data Summary (GADS) form collects 

information from applicants seeking 

grants from the Administration for 

Native Americans (ANA). Applicants 

complete the GADS form as part of their 

funding package. This standardized 

format allows ANA to evaluate 

applications for financial assistance and 

to determine the relative focus of the 

projects for which such assistance is 

requested. The data collected focuses on 

the specific ANA program area for 

which the applicant is applying. ANA 

awards annual grants in the following 

nine competitive areas: (1) Social & 

Economic Develop Strategies (SEDS); (2) 

Alaska SEDS; (3) Special Initiative: 

Family Preservation: Improving the 

Well-Being of Children Planning; (4) 

Special Initiative: Family Preservation: 

Improving the Well-Being of Children 

Implementation; (5) Native Language 

Preservation & Maintenance 

Assessment; (6) Native Language 

Preservation & Maintenance Planning; 

(7) Native Language Preservation & 

Maintenance Implementation; (8) Native 

Language Preservation & Maintenance 

Immersion; (9) Environmental 

Regulatory Enhancement. 

Respondents: Federally Recognized 

Indian Tribes, Tribal Governments, 

Native American Non-profits, Tribal 

Colleges and Universities. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of responses per 

respondent 

Average burden hours per 

response 

Total burden 

hours 

Grant Application Data Summary (GADS) ...................................................... 500 1 0.50 250 


jlentini on DSKJ8SOYB1PROD with NOTICES